Annual EBITDA
-$109.58M$67.87M+38.25%
Summary
- Current Value
- As of today, NVCR annual EBITDA is -$109.58M, up +38.25% on
- Historical Performance
- NVCR annual EBITDA is down -185.49% over the past 3 years, and down -911.13% over the past 5 years
- All-Time High Comparison
- NVCR annual EBITDA is currently -344.42% below its historical high of $44.83M set on
- 3-Year Low Comparison
- NVCR annual EBITDA is +38.25% above its 3-year low of -$177.45M reached on
- Sector Comparison
- NVCR annual EBITDA is higher than 15.34% of companies in Healthcare sector
EBITDA Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | -$109.58M | +38.3% | -185.5% | -911.1% | -59.6% | |
| Quarterly EBITDA | -$32.36M | -9.2% | -47.4% | -288.0% | -84.5% | |
| TTM EBITDA | -$162.22M | -16.4% | -173.3% | -687.6% | -824.8% | |
| Price | $13.12 | -56.3% | -82.1% | -92.4% | – | |
| PE Ratio | - | – | – | – | – | |
| Annual Revenue | $605.22M | +18.8% | +13.1% | +72.3% | +5742.5% | |
| Annual EPS | -$1.56 | +19.6% | -177.2% | -2001.9% | +74.3% | |
| Annual EBIT | -$120.82M | +35.9% | -148.4% | -2492.5% | -73.0% | |
| Annual Net Income | -$168.63M | +18.6% | -189.0% | -2232.3% | -118.0% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | -$67.89M | N/A | -61.4% |
| 5Y | $44.83M | N/A | -344.4% |
| All | $44.83M | -344.4% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | -$177.45M | +38.3% | |
| 5Y | -$177.45M | +38.3% | |
| All | -$177.45M | +38.3% |
EBITDA History
FAQ
What is the current annual EBITDA of NVCR?
As of today, NVCR annual EBITDA is -$109.58M
What is 1-year change in NVCR annual EBITDA?
NVCR annual EBITDA is up +38.25% year-over-year
What is 3-year change in NVCR annual EBITDA?
NVCR annual EBITDA is down -185.49% over the past 3 years
How far is NVCR annual EBITDA from its all-time high?
NVCR annual EBITDA is currently -344.42% below its historical high of $44.83M set on December 31, 2020
How does NVCR annual EBITDA rank versus sector peers?
NVCR annual EBITDA is higher than 15.34% of companies in Healthcare sector
When is NVCR next annual earnings release?
The next annual earnings release for NVCR is on
Quarterly EBITDA
-$32.36M$3.72M+10.31%
Summary
- Current Value
- As of today, NVCR quarterly EBITDA is -$32.36M, up +10.31% on
- Historical Performance
- NVCR quarterly EBITDA is down -9.19% year-over-year, and down -47.40% over the past 3 years
- All-Time High Comparison
- NVCR quarterly EBITDA is currently -288.02% below its historical high of $17.21M set on
- 3-Year Low Comparison
- NVCR quarterly EBITDA is +46.02% above its 3-year low of -$59.94M reached on
- Sector Comparison
- NVCR quarterly EBITDA is higher than 13.27% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | -$32.36M | +10.3% | -9.2% | -47.4% | -288.0% | |
| Annual EBITDA | -$109.58M | – | +38.3% | -185.5% | -911.1% | |
| TTM EBITDA | -$162.22M | -1.7% | -16.4% | -173.3% | -687.6% | |
| Price | $13.12 | -6.6% | -56.3% | -82.1% | -92.4% | |
| PE Ratio | - | – | – | – | – | |
| Quarterly Revenue | $167.20M | +5.3% | +7.8% | +27.6% | +26.0% | |
| Quarterly EPS | -$0.33 | +7.5% | -17.9% | -31.4% | -489.9% | |
| Quarterly EBIT | -$36.02M | +8.9% | -12.2% | -46.4% | -339.8% | |
| Quarterly Net Income | -$37.27M | +7.2% | -21.9% | -40.2% | -501.4% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$32.36M | at high | |
| 3Y | -$29.63M | -9.2% | |
| 5Y | $14.57M | N/A | -322.2% |
| All | $17.21M | -288.0% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$59.25M | N/A | +45.4% |
| 3Y | -$59.94M | +46.0% | |
| 5Y | -$59.94M | +46.0% | |
| All | -$59.94M | +46.0% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of NVCR?
As of today, NVCR quarterly EBITDA is -$32.36M
What is NVCR quarterly EBITDA most recent change?
NVCR quarterly EBITDA was up +10.31% on September 30, 2025
What is 1-year change in NVCR quarterly EBITDA?
NVCR quarterly EBITDA is down -9.19% year-over-year
How far is NVCR quarterly EBITDA from its all-time high?
NVCR quarterly EBITDA is currently -288.02% below its historical high of $17.21M set on September 30, 2020
How does NVCR quarterly EBITDA rank versus sector peers?
NVCR quarterly EBITDA is higher than 13.27% of companies in Healthcare sector
When is NVCR next earnings release?
The next earnings release for NVCR is on
TTM EBITDA
-$162.22M$2.72M-1.71%
Summary
- Current Value
- As of today, NVCR TTM EBITDA is -$162.22M, down -1.71% on
- Historical Performance
- NVCR TTM EBITDA is down -16.42% year-over-year, and down -173.32% over the past 3 years
- All-Time High Comparison
- NVCR TTM EBITDA is currently -474.42% below its historical high of $43.33M set on
- 3-Year Low Comparison
- NVCR TTM EBITDA is +24.61% above its 3-year low of -$215.19M reached on
- Sector Comparison
- NVCR TTM EBITDA is higher than 9.57% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | -$162.22M | -1.7% | -16.4% | -173.3% | -687.6% | |
| Annual EBITDA | -$109.58M | – | +38.3% | -185.5% | -911.1% | |
| Quarterly EBITDA | -$32.36M | +10.3% | -9.2% | -47.4% | -288.0% | |
| Price | $13.12 | -6.6% | -56.3% | -82.1% | -92.4% | |
| PE Ratio | - | – | – | – | – | |
| TTM Revenue | $642.27M | +1.9% | +11.2% | +18.4% | +42.8% | |
| TTM EPS | -$1.61 | -3.2% | -15.6% | -106.0% | -1011.1% | |
| TTM EBIT | -$175.76M | -2.3% | -17.0% | -151.3% | -1052.0% | |
| TTM Net Income | -$177.65M | -3.9% | -18.6% | -117.5% | -1027.6% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$154.17M | -5.2% | |
| 3Y | -$78.90M | N/A | -105.6% |
| 5Y | $43.33M | -474.4% | |
| All | $43.33M | -474.4% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$162.22M | at low | |
| 3Y | -$215.19M | +24.6% | |
| 5Y | -$215.19M | +24.6% | |
| All | -$215.19M | +24.6% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of NVCR?
As of today, NVCR TTM EBITDA is -$162.22M
What is NVCR TTM EBITDA most recent change?
NVCR TTM EBITDA was down -1.71% on September 30, 2025
What is 1-year change in NVCR TTM EBITDA?
NVCR TTM EBITDA is down -16.42% year-over-year
How far is NVCR TTM EBITDA from its all-time high?
NVCR TTM EBITDA is currently -474.42% below its historical high of $43.33M set on March 31, 2021
How does NVCR TTM EBITDA rank versus sector peers?
NVCR TTM EBITDA is higher than 9.57% of companies in Healthcare sector
When is NVCR next earnings release?
The next earnings release for NVCR is on
EBITDA Formula
EBITDA = + + +
Data Sources & References
- NVCR Official Website www.novocure.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1645113/000164511325000042/0001645113-25-000042-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1645113/000164511325000002/0001645113-25-000002-index.htm
- NVCR Profile on Yahoo Finance finance.yahoo.com/quote/NVCR
- NVCR Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/nvcr